Hanmin Lee, M.D. is Associate Professor of Surgery, and Director of the Fetal Treatment Center at UCSF. He is the second director in the 25+ year history of the Fetal Treatment Center, replacing Dr. Michael Harrison who continues to add his creative energies as Director Emeritus. Dr. Lee was an undergraduate at Johns Hopkins University who completed both medical school and general surgery residency at New York University. He did two years of postdoctoral research training under the mentorship of Dr. Jay Vacanti at Harvard Medical School, and two years of pediatric surgery fellowship at Emory University Medical Center before being recruited to a tenure-track faculty position in the Department of Surgery at UCSF in 2000.
Dr. Lee and his surgery associates confine their surgical practice exclusively to children. The group has a special interest in fetal surgery, in repair of complex defects involving the chest, lung, abdomen, bowel, and bladder, and surgical care of children from birth through adolescence. Dr. Lee and his associates, The Bay Area Pediatric Surgeons, do consultations and provide surgical care at Moffitt/Long Hospitals UCSF, California Pacific Medical Center, and Kaiser Permanente, San Francisco. They see patients regularly in their office hours and provide multidisciplinary clinics for fetal anomalies in their fetal treatment center. Additionally, they see patients with complex congenital anomalies that have been corrected by surgery in their Long-term Infant-to-adult Followup and Evaluation clinic.
Dr. Lee's clinical interests include neonatal surgery, fetal surgery, minimally invasive surgery and biliary surgery. His basic science research interests include tissue engineering, proteomic assessment of fetal-maternal diseases, and integration of emerging technologies into clinical surgery.
He has published numerous clinical and basic science articles in these fields. He is well-recognized as a leader in fetal surgery and pediatric minimally invasive surgery , having given numerous national and international talk. Additionally, he is on the editorial board of the pediatric endoscopic journal and in teaching fetal surgery and advanced pediatric laparoscopic courses. He has been a principal investigator or co-investigator on a number of fetal surgery and minimally invasive surgical trials, and is currently a co-investigator on a number of clinical trials including fetal surgery for myelomeningocele and is leading a multi-instiutional effort to investigate the role of maternal steroid administration for fetuses with large congenital cystic adenomatoid malformations.
Dr. Lee, his wife Barbara and their children, live in San Francisco and enjoy the multitude of outdoor activities and restaurants available in the Bay Area.
Surgeons at the UCSF Benioff Children's Hospital in San Francisco are using magnets to reshape the breastbones of children who suffer from Sunken Chest Syndrome. The technique is undergoing phase 3 clinical trials, but the doctors hope to prove that long term magnetic force is as effective and less painful than conventional surgery.
The Society of Clinical Trials has named UCSF's Management of Myelomeningocele Study (MOMS), a review of prenatal versus postnatal surgery for myelomengingocele (spina bifida), as its Trial of the Year. The study earned recognition as an important clinical trial that overcame difficulties and produced remarkable results.
UCSF Pediatric Surgery has published thier first interactive Patient Guide iBook for the iPad. This multimedia guidebook is a free educational resource for families who are faced with Congenital Diaphragmatic Hernia (CDH). More guidebooks are being planned as well as epub versions for other ebook readers.
The inspiration for this project is a direct result of the generous support of the CDH research and patient education grant provided by the Nayeli Faith Foundation.
Dr. Hanmin Lee has been named Surgeon in Chief of the UCSF Benioff Children's Hospital. Dr. Lee has been a champion for pediatric surgical care in the Department of Surgery for many years. He is a professor of Clinical Surgery, Pediatrics, and Obstetrics, Gynecology & Reproductive Sciences and his leadership roles include Chief of the Division of Pediatric Surgery and Director of the UCSF Fetal Treatment Center. In his new role as Surgeon in Chief, he will be responsible for inpatient and ambulatory surgical care and the continuum of preoperative, intraoperative, and postoperative care of surgical patients. He will lead the effort in building and fostering relationships with referring physicians and organizations in San Francisco and throughout the Bay Area, and will take a leadership role in the planning for operations in the new UCSF Benioff Children's Hospital at Mission Bay.
Hanmin Lee, M.D. has been selected as one of the UCSF Medical Center's "Exceptional Physicians of 2012". Dr. Lee is Professor, Surgery, Pediatrics, Ob-Gyn and Reproductive Health Services, Chief of the Division of Pediatric Surgery, Director of the UCSF Fetal Treatment Center, and the Surgeon-in-Chief of UCSF Benioff Children's Hospital. This award is given annually to physicians who have distinguished themselves as role models and demonstrate the values of UCSF Medical Center, namely professionalism, respect, integrity, diversity and excellence.
For years, surgeons have been seeking ways of operating on babies in the womb, reasoning that medical abnormalities are easier to address while the fetus is still developing. Now, for the first time, a large clinical trial has shown that fetal surgery can also benefit infants with non life-threatening conditions. The eight-year study reported in the New England Journal of Medicine, found that babies born with myelomeningocele, the most common form of spina bifida, a debilitating spinal abnormality, were twice as likely to walk and experienced fewer neurological problems with in utero repair versus standard post-natal repair.
UCSF announces the formation of the Institute for Fetal and Neonatal Health symposium brings together clinicians and basic scientists involved in different aspects of development and fetal intervention.
As the new Director of the Fetal Treatment Center, Dr. Hanmin Lee will continue the Center's and its co-founder Dr. Michael Harrison's pioneering spirit of multidisciplinary research and innovation to improve our understanding of fetal disease and further advance the treatment and management of infants and children. Dr. Harrison will continue as Director Emeritus of the Fetal Treatment Center.